Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BXBLY | LEN |
|---|---|---|
| Price | $26.98 | $74.44 |
| Change today | ▲ 1.35% | ▼ 6.73% |
| Market cap | $17.69B | $17.71B |
| Return, 3 months | +2.9% | -13.7% |
| Return, year to date | -8.8% | -26.5% |
| Return, 1 year | -15.6% | -39.9% |
| P/E (TTM) | 19.4 | 14.1 |
| P/B | 5.6 | 0.8 |
| P/E percentile vs own 5y | – | 100th |
| Dividend yield | 3.50% | 2.69% |
| Revenue growth (YoY, latest qtr) | – | -8.7% |
| Net profit growth (YoY) | – | -52.4% |
| Gross margin | – | 13.8% |
| Operating margin | – | 5.6% |
| Net margin | – | 4.1% |
| Return on equity | – | 5.9% |
| Analyst target vs. price | – | +6.4% |
| Analyst buy share | – | 8% |
| RSI (14) | 54 | 35 |
| 30-day volatility | 18.6% | 39.7% |
| Max drawdown, 1 year | -34.3% | -43.2% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.